2017
DOI: 10.1016/j.injury.2016.08.016
|View full text |Cite
|
Sign up to set email alerts
|

Direct oral anticoagulants compared with warfarin in patients with severe blunt trauma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(18 citation statements)
references
References 11 publications
0
18
0
Order By: Relevance
“…In line with our findings, Feeney et al also reported a higher mortality in 162 TBI patients with concomitant VKA intake than in DOAC patients. In the VKA group, the need for surgical interventions (26.7% vs. 8.2%, p = 0.023) and mortality (20.9% vs. 4.9%, p < 0.008) were significantly higher than in the DOAC group [ 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…In line with our findings, Feeney et al also reported a higher mortality in 162 TBI patients with concomitant VKA intake than in DOAC patients. In the VKA group, the need for surgical interventions (26.7% vs. 8.2%, p = 0.023) and mortality (20.9% vs. 4.9%, p < 0.008) were significantly higher than in the DOAC group [ 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…One theory is the increasing use of the new oral anticoagulants, which are challenging to reverse. Recent studies, however, suggest that these medications are actually improving outcomes in injured trauma patients . Perhaps this mortality increase is simply a reflection of an aging U.S. population with increasing comorbidities .…”
Section: Discussionmentioning
confidence: 99%
“…A study of 162 patients on preinjury anticoagulant therapy with blunt traumatic injuries and an AIS head score of < 4 found a significantly lower mortality in patients taking DOACs (4.9%) as compared to warfarin (20.8%). 27 Similiarly, a study looking at 186 older adults with TBI on preinjury anticoagulants and found an increased in-hospital mortality with warfarin as compared to DOACs despite adequate reversal agent administration in the warfarin group. 28 Our study, as well as those previously reported, should serve as hypothesis generating for a larger analysis directly comparing preinjury warfarin to DOAC.…”
Section: Author Manuscriptmentioning
confidence: 99%